User profiles for David A. Kass

David A. Kass

Johns Hopkins University
Verified email at jhmi.edu
Cited by 83311

[HTML][HTML] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

…, J Boehmer, S Krueger, DA Kass… - … England Journal of …, 2004 - Mass Medical Soc
Background We tested the hypothesis that prophylactic cardiac-resynchronization therapy
in the form of biventricular stimulation with a pacemaker with or without a defibrillator would …

Mechanisms, pathophysiology, and therapy of arterial stiffness

SJ Zieman, V Melenovsky, DA Kass - … , thrombosis, and vascular …, 2005 - Am Heart Assoc
Arterial stiffness is a growing epidemic associated with increased risk of cardiovascular
events, dementia, and death. Decreased compliance of the central vasculature alters arterial …

Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function

…, B Fetics, PH Pak, FCP Yin, WL Maughan, DA Kass - Circulation, 1997 - Am Heart Assoc
Background Central aortic pressures and waveform convey important information about
cardiovascular status, but direct measurements are invasive. Peripheral pressures can be …

Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay

DA Kass, CH Chen, C Curry, M Talbot, R Berger… - Circulation, 1999 - Am Heart Assoc
Background—Ventricular pacing can improve hemodynamics in heart failure patients, but
direct effects on left ventricular (LV) function from varying pacing site and atrioventricular (AV) …

Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials

…, RD Berger, H Calkins, SN Goodman, DA Kass… - Jama, 2003 - jamanetwork.com
Context Progressive heart failure is the most common mechanism of death among patients
with advanced heart failure. Cardiac resynchronization, a pacemaker-based therapy for heart …

Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve …

M Kawaguchi, I Hay, B Fetics, DA Kass - Circulation, 2003 - Am Heart Assoc
Background— Heart failure with preserved ejection fraction (HF-nlEF) is common in aged
individuals with systolic hypertension and is frequently ascribed to diastolic dysfunction. We …

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

…, D Bedja, KL Gabrielson, Y Wang, DA Kass - Nature medicine, 2005 - nature.com
Sustained cardiac pressure overload induces hypertrophy and pathological remodeling,
frequently leading to heart failure. Genetically engineered hyperstimulation of guanosine 3′,5…

Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block

…, BJ Fetics, M Talbot, JC Spinelli, JM Hare, DA Kass - Circulation, 2000 - Am Heart Assoc
Background—Left ventricular or biventricular pacing/stimulation can acutely improve systolic
function in patients with dilated cardiomyopathy (DCM) and intraventricular conduction …

Age-and gender-related ventricular-vascular stiffening: a community-based study

…, SJ Jacobsen, BA Borlaug, RJ Rodeheffer, DA Kass - Circulation, 2005 - Am Heart Assoc
Background— Increases in vascular (Ea), ventricular systolic (Ees), and ventricular diastolic
(Ed) elastance (stiffness) may contribute to the pathogenesis of heart failure (HF) with …

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

DA Kass, EP Shapiro, M Kawaguchi, AR Capriotti… - Circulation, 2001 - Am Heart Assoc
Background Arterial stiffening with increased pulse pressure is a leading risk factor for
cardiovascular disease in the elderly. We tested whether ALT-711, a novel nonenzymatic breaker …